Cited by 118Hormonal Regulation and HypertensionParathyroid Disorders and TreatmentsPotassium and Related Disorders

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Hyperparathyroidism in Patients with Primary Aldosteronism: Cross-Sectional and Interventional Data from the GECOH Study

Open access

Pilz, Stefan, Kienreich, Katharina, Drechsler, Christiane, Ritz, Eberhard, Fahrleitner-Pammer, Astrid, Gaksch, Martin, Meinitzer, Andreas, März, Winfried, Pieber, Thomas R., Tomaschitz, Andreas·2012·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2011-2183

Open this paper in CoChat — free account Open PDF

Abstract

Context: Experimental studies suggest that aldosterone induces hypercalciuria and might contribute to hyperparathyroidism. Objective: We aimed to test for differences in PTH levels and parameters of calcium and vitamin D metabolism in patients with primary aldosteronism (PA) compared with patients with essential hypertension (EH) and to evaluate the impact of PA treatment on these laboratory values. Design, Setting, and Participants: The Graz Endocrine Causes of Hypertension study includes hypertensive patients referred for screening for endocrine hypertension at a tertiary care center in Graz, Austria. Main Outcome Measures: Differences in PTH levels between patients with PA and EH. Results: Among 192 patients, we identified 10 patients with PA and 182 with EH. PTH levels (mean ± sd in picograms per milliliter) were significantly higher in PA patients compared with EH (67.8 ± 26.9 vs. 46.5 ± 20.9; P = 0.002). After treatment of PA with either adrenal surgery (n = 5) or mineralocorticoid receptor antagonists (n = 5), PTH concentrations decreased to 43.9 ± 14.9 (P = 0.023). Serum 25-hydroxyvitamin D concentrations were similar in both groups. Compared with EH, serum calcium concentrations were significantly lower (2.35 ± 0.10 vs. 2.26 ± 0.10 mmol/liter; P = 0.013), and there was a nonsignificant trend toward an increased spot urine calcium to creatinine ratio in PA [median (interquartile range) 0.19 (0.11–0.31) vs. 0.33 (0.12–0.53); P = 0.094]. Conclusions: Our results suggest that PA contributes to secondary hyperparathyroidism. Further studies are warranted to evaluate whether PTH has implications for PA diagnostics and whether mineralocorticoid receptor antagonists have a general impact on PTH and calcium metabolism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1210/jc.2011-2183

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541
Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community
Hagström, E., Hellman, P., Larsson, T. E., Ingelsson, E., Berglund, L., Sundström, J., Melhus, H., Held, C., Lind, L., Michaëlsson, K., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.808733 · Cited by 416
Hyperparathyroidism and the Calcium Paradox of Aldosteronism
Chhokar, V. S., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., Myers, L. K., Xing, Z., Smith, R. A., Gerling, I., & Weber, K. T. (2005) · Circulation · doi:10.1161/01.cir.0000155621.10213.06 · Cited by 208
Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography
Pilz, S., Tomaschitz, A., Drechsler, C., Ritz, E., Boehm, B. O., Grammer, T. B., & Marz, W. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq109 · Cited by 161
Self-citation
Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas
Rossi, E., Sani, C., Perazzoli, F., Casoli, M. C., Negro, A., & Dotti, C. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00182-o · Cited by 134
Calcium metabolism and parathyroid function in primary aldosteronism
Resnick, L. M., & Laragh, J. H. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90328-6 · Cited by 111
Calcium paradox of aldosteronism and the role of the parathyroid glands
Vidal, A., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., Gerling, I., & Weber, K. T. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00535.2005 · Cited by 94
Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems.
Gennari, C., Nami, R., & Gonnelli, S. (1995) · PubMed · Cited by 86
Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism
Brunaud, L., Germain, A., Zarnegar, R., Rancier, M., Alrasheedi, S., Caillard, C., Ayav, A., Weryha, G., Mirallie, E., & Bresler, L. (2009) · Surgery · doi:10.1016/j.surg.2009.09.041 · Cited by 83
Effect of chronic mineralocorticoid administration on calcium excretion in the rat
Suki, W., Schwettmann, R., Rector, F. C., & Dw, S. (1968) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1968.215.1.71 · Cited by 83

Flagged first, then by citations

Show all 21 references

Sorted by citations

Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease
Tomaschitz, A., Ritz, E., Pieske, B. M., Rus-Machan, J., Kienreich, K., Verheyen, N., Gaksch, M., Grübler, M. R., Fahrleitner‐Pammer, A., Mrak, P., et al. (2013) · Metabolism · doi:10.1016/j.metabol.2013.08.016 · Cited by 169
Self-citation
Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney
Stowasser, M., & Gordon, R. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00026.2015 · Cited by 162
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism
Rossi, G. P., Bisogni, V., Bacca, A., Belfiore, A., Cesari, M., Concistrè, A., Pinto, R. D., Fabris, B., Fallo, F., Fava, C., et al. (2020) · International Journal of Cardiology Hypertension · doi:10.1016/j.ijchy.2020.100029 · Cited by 140
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease
Tomaschitz, A., Ritz, E., Pieske, B. M., Fahrleitner‐Pammer, A., Kienreich, K., Horina, J. H., Drechsler, C., März, W., Ofner, M., Pieber, T. R., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs092 · Cited by 129
Self-citation
Bone involvement in aldosteronism
Salcuni, A. S., Palmieri, S., Carnevale, V., Morelli, V., Battista, C., Guarnieri, V., Guglielmi, G., Desina, G., Eller-Vainicher, C., Beck-Peccoz, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1660 · Cited by 101
The renin–angiotensin–aldosterone system and calcium-regulatory hormones
Vaidya, A., Brown, J. M., & Williams, J. S. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2014.125 · Cited by 93
Human Interventions to Characterize Novel Relationships Between the Renin–Angiotensin–Aldosterone System and Parathyroid Hormone
Brown, J. M., Williams, J. S., Luther, J. M., Garg, R., Garza, A. E., Pojoga, L. H., Ruan, D. T., Williams, G. H., Adler, G. K., & Vaidya, A. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.01910 · Cited by 88
Bone health and aldosterone excess
Ceccoli, L., Ronconi, V., Giovannini, L., Marcheggiani, M., Turchi, F., Boscaro, M., & Giacchetti, G. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2399-1 · Cited by 85
Hyperparathyroidism Can Be Useful in the Identification of Primary Aldosteronism Due To Aldosterone-Producing Adenoma
Rossi, G. P., Ragazzo, F., Seccia, T. M., Maniero, C., Barisa, M., Calò, L. A., Frigo, A. C., Fassina, A., & Pessina, A. C. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195891 · Cited by 76
Interpretation of Plasma PTH Concentrations According to 25OHD Status, Gender, Age, Weight Status, and Calcium Intake: Importance of the Reference Values
Touvier, M., Deschasaux, M., Montourcy, M., Sutton, A., Charnaux, N., Kesse‐Guyot, E., Fezeu, L., Latino‐Martel, P., Druesne‐Pecollo, N., Malvy, D. J.-M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3349 · Cited by 72
Aldosterone, Parathyroid Hormone, and the Use of Renin-Angiotensin-Aldosterone System Inhibitors: The Multi-Ethnic Study of Atherosclerosis
Brown, J., de Boer, I. H., Robinson-Cohen, C., Siscovick, D. S., Kestenbaum, B., Allison, M., & Vaidya, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3949 · Cited by 71
Vitamin D3 Therapy Corrects the Tissue Sensitivity to Angiotensin II Akin to the Action of a Converting Enzyme Inhibitor in Obese Hypertensives: An Interventional Study
Vaidya, A., Sun, B., Larson, C., Forman, J. P., & Williams, J. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1156 · Cited by 68
Bone and Mineral Metabolism in Patients with Primary Aldosteronism
Petramala, L., Zinnamosca, L., Settevendemmie, A., Marinelli, C., Nardi, M., Concistrè, A., Corpaci, F., Tonnarini, G., Toma, G. D., & Letizia, C. (2014) · International Journal of Endocrinology · doi:10.1155/2014/836529 · Cited by 65
The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
Zheng, M.-H., Li, F., Xu, F., Lin, X., Wang, Y., Xu, Q.-S., Guo, B., & Yuan, L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00539 · Cited by 69
Mineral metabolism and cardiovascular disease in CKD
Fujii, H., & Joki, N. (2017) · Clinical and Experimental Nephrology · doi:10.1007/s10157-016-1363-8 · Cited by 61
Elevation of Angiotensin-II Type-1-Receptor Autoantibodies Titer in Primary Aldosteronism as a Result of Aldosterone-Producing Adenoma
Rossitto, G., Regolisti, G., Rossi, E., Negro, A., Nicoli, D., Casali, B., Toniato, A., Caroccia, B., Seccia, T. M., Walther, T., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.202945 · Cited by 60
Primary aldosteronism as a cause of secondary osteoporosis
Salcuni, A. S., Carnevale, V., Battista, C., Palmieri, S., Eller-Vainicher, C., Guarnieri, V., Pugliese, F., Guglielmi, G., Desina, G., Minisola, S., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0417 · Cited by 49
Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study
Fernández-Argüeso, M., Corrales, E. P., Rojano, N. B., Cano, A. M. G., Mendiguchía, L. J., & Castro, M. A. (2021) · Endocrine · doi:10.1007/s12020-021-02704-2 · Cited by 43
Lower Trabecular Bone Score in Patients With Primary Aldosteronism: Human Skeletal Deterioration by Aldosterone Excess
Kim, B., Kwak, M. K., Ahn, S. H., Kim, H., Lee, S. H., & Koh, J. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02043 · Cited by 41
Primary Aldosteronism and Bone Metabolism: A Systematic Review and Meta-Analysis
Shi, S., Lu, C., Tian, H., Ren, Y., & Chen, T. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.574151 · Cited by 40
Interactions between adrenal-regulatory and calcium-regulatory hormones in human health
Brown, J. M., & Vaidya, A. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000062 · Cited by 39
Association between Parathyroid Hormone and Cardiovascular Disease
Fujii, H. (2018) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12679 · Cited by 41
A High Aldosterone to Renin Ratio Is Associated With High Serum Parathyroid Hormone Concentrations in the General Population
Fischer, E., Hannemann, A., Rettig, R., Lieb, W., Nauck, M., Pallauf, A., Bildingmaier, M., Beuschlein, F., Wallaschofski, H., & Reincke, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3214 · Cited by 37
PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy
Lenzini, L., Prisco, S., Vanderriele, P. E., Lerco, S., Torresan, F., Maiolino, G., Seccia, T. M., Iacobone, M., & Rossi, G. P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00143 · Cited by 33
The molecular basis of primary aldosteronism: from chimeric gene to channelopathy
Lenzini, L., & Rossi, G. P. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.005 · Cited by 31
Hypertension, Antihypertensive Medications, and Risk of Incident Primary Hyperparathyroidism
Vaidya, A., Curhan, G. C., Paik, J. M., Kronenberg, H. M., & Taylor, E. N. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1619 · Cited by 29
Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk
Tomaschitz, A., Pilz, S., Rus-Machan, J., Meinitzer, A., Brandenburg, V. M., Scharnagl, H., Kapl, M., Grammer, T., Ritz, E., Horina, J. H., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.062 · Cited by 27
Self-citation
Disentangling the Relationships Between the Renin–Angiotensin–Aldosterone System, Calcium Physiology, and Risk for Kidney Stones
Bayomy, O. F., Zaheer, S., Williams, J. S., Curhan, G. C., & Vaidya, A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa123 · Cited by 27
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial
Tomaschitz, A., Fahrleitner‐Pammer, A., Pieske, B. M., Verheyen, N., Amrein, K., Ritz, E., Kienreich, K., Horina, J. H., Schmidt, A. G., Kraigher‐Krainer, E., et al. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-19 · Cited by 26
Self-citation
Primary and Secondary Hyperparathyroidism in Patients with Primary Aldosteronism – Findings From the German Conn’s Registry
Asbach, E., Bekeran, M., König, A., Lang, K., Hanslik, G., Treitl, M., Ladurner, R., Bidlingmaier, M., Beuschlein, F., Quinkler, M., et al. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1027-6472 · Cited by 25
Effectiveness of Spironolactone in Reducing Osteoporosis and Future Fracture Risk in Middle-Aged and Elderly Hypertensive Patients
Song, S., Cai, X., Hu, J., Zhu, Q., Shen, D., Ma, H., Zhang, Y., Ma, R., Yang, W., Hong, J., et al. (2024) · Drug Design, Development and Therapy · doi:10.2147/dddt.s466904 · Cited by 25
Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications
Tomaschitz, A., Piecha, G., Ritz, E., Meinitzer, A., Haas, J. G., Pieske, B. M., Więcek, A., Rus-Machan, J., Toplak, H., März, W., et al. (2014) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2014.913604 · Cited by 25
Self-citation
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial
Tomaschitz, A., Verheyen, N., Meinitzer, A., Pieske, B., Belyavskiy, E., Brussee, H., Haas, J., März, W., Pieske-Kraigher, E., Verheyen, S., et al. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000927 · Cited by 24
Self-citation
Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial
Verheyen, N., Fahrleitner-Pammer, A., Pieske, B., Meinitzer, A., Belyavskiy, E., Wetzel, J., Gaksch, M., Grübler, M. R., Catena, C., Sechi, L. A., et al. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001004 · Cited by 24
Self-citation
Parathyroid Gland Function in Primary Aldosteronism
Bekeran, M., Reincke, M., & Asbach, E. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565224 · Cited by 22
The Endocrine Role of Bone in Cardiometabolic Health
DeLuccia, R., Cheung, M. M., Ramadoss, R. K., Aljahdali, A., & Sukumar, D. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-00286-0 · Cited by 20
Factors affecting parathyroid hormone levels in different types of primary aldosteronism
Jiang, Y., Zhang, C., Ye, L., Su, T., Zhou, W., Jiang, L., Zhang, Y., & Wang, W. (2015) · Clinical Endocrinology · doi:10.1111/cen.12981 · Cited by 20
Acute and long-term kidney function after parathyroidectomy for primary hyperparathyroidism
Belli, M., Martin, R. M., Brescia, M. D. G., do Nascimento, C. P., Neto, L. M. M., Arap, S., Ferraz‐de‐Souza, B., Moysés, R. M. A., Peacock, M., & Montenegro, F. L. D. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244162 · Cited by 18
Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea—what do we know so far?
Loh, H. H., & Sukor, N. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0294-8 · Cited by 19
Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels
Tuersun, T., Luo, Q., Zhang, Z., Wang, G., Zhang, D., Wang, M., Wu, T., Zhou, K., Yue, N., & Li, N. (2020) · Hypertension Research · doi:10.1038/s41440-020-0529-7 · Cited by 18
Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis
Wang, A., Wang, Y., Liu, H., Hu, X., Li, J., Xu, H., Nie, Z., Zhang, L., & Lyu, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1027841 · Cited by 20
Adrenal disorders: Is there Any role for vitamin D?
Tirabassi, G., Salvio, G., Altieri, B., Ronchi, C. L., Casa, S. D., Pontecorvi, A., & Balercia, G. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9391-y · Cited by 18
Interplay Between Sodium and Calcium Regulatory Hormones
Tomaschitz, A., & Pilz, S. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02253 · Cited by 18
Self-citation
The effect of vitamin D treatment on clinical and biochemical outcomes of primary aldosteronism
Ismail, N. A., Kamaruddin, N. A., Shah, S. A., & Sukor, N. (2020) · Clinical Endocrinology · doi:10.1111/cen.14177 · Cited by 17
Bone Health in Adrenal Disorders
Kim, B., Lee, S. H., & Koh, J. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.1.1 · Cited by 17
Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives
Altieri, B., Muscogiuri, G., Paschou, S. Α., Vryonidou, A., Casa, S. D., Pontecorvi, A., Faßnacht, M., Ronchi, C. L., & Newell-Price, J. D. C. (2018) · Endocrine · doi:10.1007/s12020-018-1696-z · Cited by 16
Interplay of parathyroid hormone and aldosterone antagonist in prevention of heart failure hospitalizations in chronic kidney disease
Hassan, M., Qureshi, W., Sroujieh, L. S., Albashaireh, D., BouMalham, S., Liroff, M., Amjad, W., Khalid, F., Hadid, H., & Alirhayim, Z. (2014) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320314539180 · Cited by 15
Online prediction model for primary aldosteronism in patients with hypertension in Chinese population: A two-center retrospective study
Lin, W., Gan, W., Feng, P., Zhong, L., Yao, Z., Chen, P., He, W., & Yu, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.882148 · Cited by 14
Associations of Sun Exposure with 25-Hydroxyvitamin D and Parathyroid Hormone Levels in a Cohort of Hypertensive Patients: The Graz Endocrine Causes of Hypertension (GECOH) Study
Pilz, S., Kienreich, K., Stückler, D., Meinitzer, A., & Tomaschitz, A. (2012) · International Journal of Endocrinology · doi:10.1155/2012/732636 · Cited by 14
Self-citation
Diagnostic Accuracy of the Aldosterone–to–Active Renin Ratio for Detecting Primary Aldosteronism
Pilz, S., Keppel, M. H., Trummer, C., Theiler‐Schwetz, V., Pandis, M., Borzan, V., Pittrof, M., Obermayer-Pietsch, B. M., Grübler, M. R., Verheyen, N., et al. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00145 · Cited by 14
Self-citation
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data
Pilz, S., Trummer, C., Verheyen, N., Theiler‐Schwetz, V., Pandis, M., Aberer, F., Grübler, M. R., Meinitzer, A., Bachmann, A., Voelkl, J. G. J., et al. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0604-3249 · Cited by 13
Self-citation
Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion
Zaheer, S., Brown, J. M., Connors, M., Williams, J. S., Adler, G. K., & Vaidya, A. (2017) · International Journal of Endocrinology · doi:10.1155/2017/4138783 · Cited by 12
The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetes
Vaidya, A., UNDERWOOD, P. C., Annes, J. P., Sun, B., Williams, G. H., Forman, J. P., & Williams, J. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.10.001 · Cited by 11
Secondary Hypertension Due To Concomitant Aldosterone-Producing Adenoma and Parathyroid Adenoma
Chau, K., Holmes, D. T., Melck, A. L., & Chan-Yan, C. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu102 · Cited by 11
Vitamin D and adrenal gland: Myth or reality? A systematic review
Refaie, A. F. A., Baldassini, L., Vita, M. D., Gonnelli, S., & Caffarelli, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1001065 · Cited by 11
Bone health among patients with primary aldosteronism: a systematic review and meta-analysis
Loh, H. H., Yee, A. H. A., & Loh, H. S. (2020) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02867-5 · Cited by 11
Accentuated hyperparathyroidism in type II Bartter syndrome
Landau, D., Gurevich, E., Sinay-Trieman, L., & Shalev, H. (2016) · Pediatric Nephrology · doi:10.1007/s00467-016-3337-1 · Cited by 11
Relationship between parathyroid hormone and renin–angiotensin–aldosterone system in hemodialysis patients with secondary hyperparathyroidism
Kono, K., Fujii, H., Watanabe, K., Goto, S., & Nishi, S. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01139-5 · Cited by 10
Risk Factors Associated With Lower Bone Mineral Density in Primary Aldosteronism Patients
Lv, X., Hu, H., Shen, C., Zhang, X., Yan, L., Zhang, S., & Guo, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.884302 · Cited by 10
Primary aldosteronism with concurrent primary hyperparathyroidism: clinical case load in a single centre.
Concistrè, A., Petramala, L., Zinnamosca, L., Settevendemmie, A., Corpaci, F., Marinelli, C., Tonnarini, G., D’Ermo, G., Toma, G. D., & Letizia, C. (2015) · PubMed · Cited by 10
Association Between Aldosterone and Parathyroid Hormone Levels in Patients With Adrenocortical Tumors
Zavatta, G., Dalmazi, G. D., Altieri, P., Pelusi, C., Golfieri, R., Mosconi, C., Balacchi, C., Borghi, C., Cosentino, E. R., Cintio, I. D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.09.002 · Cited by 11
PTH Is a Promising Auxiliary Index for the Clinical Diagnosis of Aldosterone-Producing Adenoma
Zhang, L., Gu, W., Li, Y., Wang, Y., Wang, W., Wang, A., Shen, L., Zang, L., Yang, G., Lü, Z., et al. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv146 · Cited by 10
The Molecular Mechanisms Underlying the Systemic Effects Mediated by Parathormone in the Context of Chronic Kidney Disease
Maranducă, M. A., Cozma, C. T., Clim, A., Pînzariu, A. C., Tudorancea, I., Popa, I. P., Lazăr, C. I., Moscalu, R., Filip, N., Moscalu, M., et al. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050241 · Cited by 8
The Importance of Correlation between Aldosterone and Parathyroid Hormone in Patients with Primary Hyperparathyroidism
Stanić, B. M., Ilinčić, B., Žeravica, R., Ivanovski, D. M., Čabarkapa, V., & Mijović, R. (2022) · International Journal of Endocrinology · doi:10.1155/2022/3804899 · Cited by 8
The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension
Keppel, M. H., Piecha, G., März, W., Cadamuro, J., Auer, S., Felder, T. K., Mrazek, C., Oberkofler, H., Trummer, C., Grübler, M. R., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212973 · Cited by 8
Self-citation
Primary Aldosteronism with Concurrent Primary Hyperparathyroidism in a Patient with Arrhythmic Disorders
Petramala, L., Savoriti, C., Zinnamosca, L., Marinelli, C., Settevendemmie, A., Calvieri, C., Catani, M., & Letizia, C. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.8794 · Cited by 8
Primary aldosteronism 2.0: an update for clinicians on diagnosis and treatment
Pilz, S., Kocjan, T., Theiler‐Schwetz, V., & Trummer, C. (2023) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16585 · Cited by 7
Self-citation
Association of serum parathyrine and calcium levels with primary aldosteronism: a meta-analysis.
Zhang, Y., & Feng, B. (2015) · PubMed · Cited by 7
Disease monitoring of Primary Aldosteronism
Rossi, G. P., Cesari, M., Lenzini, L., & Seccia, T. M. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101417 · Cited by 7
Primary Aldosteronism with Parathyroid Hormone Elevation: A Single-center Retrospective Study
Kometani, M., Yoneda, T., Aono, D., Noda, Y., Matsuoka, T., Higashitani, T., Yoshikura, S., Sawada, K. B., Takeda, Y., Fujimoto, A., et al. (2021) · Internal Medicine · doi:10.2169/internalmedicine.5282-20 · Cited by 7
Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism: report of a case
Hibi, Y., Hayakawa, N., Hasegawa, M., Ogawa, K., Shimizu, Y., Shibata, M., Kagawa, C., Mizuno, Y., Yuzawa, Y., Itoh, M., et al. (2013) · Surgery Today · doi:10.1007/s00595-013-0813-0 · Cited by 7
Relationship Between Aldosterone and Parathyroid Hormone, and the Effect of Angiotensin and Aldosterone Inhibition on Bone Health
Bislev, L. S., Sikjær, T., Rolighed, L., & Rejnmark, L. (2015) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-015-9182-0 · Cited by 8
Connecting the dots: renin-angiotensin-aldosterone system, vitamin D, and hypertension
Loh, H. H., Azizan, E. A., & Sukor, N. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000004046 · Cited by 6
Cross-Disciplinary Approach of Adrenal Tumors: Insights into Primary Aldosteronism-Related Mineral Metabolism Status and Osteoporotic Fracture Risk
Trandafir, A.-I., Gheorghe, A.-M., Sima, O.-C., Ciuche, A., Petrova, E. N., Nistor, C., & Carşote, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417338 · Cited by 6
Saline suppression testing-induced hypocalcemia and implications for clinical interpretations
Parksook, W. W., Brown, J. M., Milks, J., Tsai, L. C., Chan, J., Moore, A., Niebuhr, Y., Honzel, B., Newman, A. J., & Vaidya, A. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae099 · Cited by 6
Changes in PTH Across the Spectrum of Renin-independent Aldosteronism
Ooi, A., Khan, H., Akram, M., Fuller, P. J., Milat, F., Yang, J., & Libianto, R. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf151 · Cited by 6
Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection
Chan, C., Chang, Y., Tsai, Y., Chen, Z., Wu, C.-Y., Huang, W., Yen, I., Wu, K.-H., Wu, V., Lin, Y., et al. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.03.032 · Cited by 6
Endocrine Hypertension
Zhang, W., Wang, Y., Wei, Z. C., Chang, G., Luo, Q., Abudusailamu, N., Nurula, M., Tao, S., Li, H., & Chen, Y. (2019) · Springer eBooks · doi:10.1007/978-981-15-0591-1_9 · Cited by 5
Hyperparathyroidism in patients with overt and mild primary aldosteronism
Gravvanis, C., Papanastasiou, L., Glycofridi, S., Voulgaris, N., Tyfoxylou, E., Kounadi, T., Piaditis, G. P., & Markou, Α. (2021) · HORMONES · doi:10.1007/s42000-021-00319-w · Cited by 5
Aldosterone Secretion in Patients With Primary Hyperparathyroidism Without Arterial Hypertension
Castellano, E., Pellegrino, M., Tardivo, V., Attanasio, R., Boriano, A., & Borretta, G. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.886 · Cited by 4
Primärer Hyperaldosteronismus: Diagnostik und Therapie
Pilz, S., Tomaschitz, A., Trummer, C., Bachmann, A., Pandis, M., Theiler‐Schwetz, V., Obermayer-Pietsch, B. M., & März, W. (2017) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-017-0010-7 · Cited by 4
Self-citation
Primary aldosteronism — recent progress and current concepts
Kołodziejczyk‐Kruk, S., Januszewicź, W., Pęczkowska, M., Prejbisz, A., Zgliczyński, W., & Januszewicz, A. (2013) · Endokrynologia Polska · doi:10.5603/ep.2013.0011 · Cited by 3
Impact of Endocrine Disorders on Blood Pressure
Carbone, F., Bonaventura, A., Vecchié, A., Casula, M., Liberale, L., Dallegri, F., & Montecucco, F. (2020) · Endocrinology · doi:10.1007/978-3-319-68729-2_2 · Cited by 3
Systematic approach to the diagnosis and management of endocrine hypertension
Stowasser, M., Jansen, P. M., & Wolley, M. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00009-1 · Cited by 4
Aldosterone and Parathyroid Hormone: Evidence for a Clinically Relevant Relationship
Naik, V. (2019) · Journal of Endocrinology and Thyroid Research · doi:10.19080/jetr.2019.04.555637 · Cited by 3
A case of primary aldosteronism with secondary hyperparathyroidism and bilateral adrenal tumors
Eguchi, T., & Miyauchi, S. (2015) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-15-0029 · Cited by 2
Double hit! A unique case of resistant hypertension
DeCarlo, K., & Agrawal, N. (2017) · BMJ Case Reports · doi:10.1136/bcr-2017-221530 · Cited by 2
Different roles of the RAAS affect bone metabolism in patients with primary aldosteronism, Gitelman syndrome and Bartter syndrome
Tang, W., Chai, Y., Jia, H., Wang, B., Liu, T., Wang, H., & Dai, C. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00955-2 · Cited by 2
Effects of Altered Calcium Metabolism on Cardiac Parameters in Primary Aldosteronism
Lim, J. S., Hong, N., Park, S., Park, S. I., Oh, Y. T., Yu, M. H., Lim, P. Y., & Rhee, Y. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.4.485 · Cited by 2
Clinical-Pathological Conference Series from the Medical University of Graz
Fabian, E., Schneeweiß, B., Valentin, T., Flick, H., Aigelsreiter, A., Hofmann‐Wellenhof, R., Cerroni, L., Goritschan, A., Brezinsek, H. P., Zitta, S., et al. (2017) · Wiener klinische Wochenschrift · doi:10.1007/s00508-016-1164-9 · Cited by 2
Impact of Parathormone (PTH) Levels on the Presence of Cardiovascular Disease in Patients with Primary Aldosteronism and Essential Hypertension
Fernández-Sánchez, Á., Meneses, D., Bellassai, E. R. A., Cárdenas‐Salas, J., Paniagua, A., Vázquez, C., & Ruiz-Sánchez, J. G. (2025) · Endocrines · doi:10.3390/endocrines6010008 · Cited by 1
Primärer Hyperaldosteronismus – Guideline der Endocrine Society 2025
Pilz, S., Schmitt, L., Kraus, D. A., Theiler‐Schwetz, V., Trummer, C., & Riedmann, U. (2025) · Journal für Endokrinologie Diabetologie und Stoffwechsel · doi:10.1007/s41969-025-00291-5 · Cited by 1
Self-citation
Mediastinal Parathyroidectomy: Preoperative Management of Hyperparathyroidism
Sagan, D., Jerzy, S., Nowakowski, A. M., Klatka, M., Czekajska−Chehab, E., Drop, A., Chrapko, B. E., & Klatk, J. (2012) · InTech eBooks · doi:10.5772/38188 · Cited by 1
Clinical-Pathological Conference Series from the Medical University of Graz
Fabian, E., Schiller, D., Tomaschitz, A., Langner, C., Pilz, S., Quasthoff, S., Raggam, R. B., Schoefl, R., & Krejs, G. J. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-016-1085-7 · Cited by 1
Self-citation
Primary aldosteronism complicated by hyperparathyroidism: report of one case and literature review.
Zhou, D.-D., Liu, M., & Yan, Z. (2019) · Europe PMC (PubMed Central) · Cited by 1
Evaluating the clinical and mechanistic effects of eplerenone and amiloride monotherapy, and combination therapy with cinacalcet, in primary hyperparathyroidism: A placebo‐controlled randomized trial
Parksook, W. W., Heydarpour, M., Brown, J. M., Turchin, A., Mannstadt, M., & Vaidya, A. (2022) · Clinical Endocrinology · doi:10.1111/cen.14840 · Cited by 1
Research progress on the correlation between primary aldosteronism and bone metabolism
Chai, Y. (2022) · Frontiers in Medical Science Research · doi:10.25236/fmsr.2022.041308 · Cited by 1
The prevalence of primary and secondary hyperparathyroidism and its cardiometabolic implications in primary aldosteronism
Castro, M. A., Corrales, E. P., Fernández-Argüeso, M., BENGOA-ROJANO, N., Cano, A. M. G., Mendiguchía, L. J., & Cuesta, M. (2023) · Minerva Endocrinology · doi:10.23736/s2724-6507.23.03866-6 · Cited by 1
Aldosterone and Cardiovascular Diseases
Tomaschitz, A., & Pilz, S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_12
Self-citation
Die Rolle von Aldosteron im Knochenstoffwechsel
Tomaschitz, A., Kienreich, K., Fahrleitner‐Pammer, A., & Pilz, S. (2012) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Self-citation

Authors: Pilz, S., Kienreich, K., Drechsler, C., Ritz, E., Fahrleitner-Pammer, A., Gaksch, M., Meinitzer, A., März, W., Pieber, T. R., & Tomaschitz, A.
Affiliations: Amsterdam Public Health (NL)
Department of Internal Medicine (S.P., K.K., A.F.-P., M.G., T.R.P., A.T.), 8036 Graz, Austria
University of Würzburg (DE)
University Hospital Heidelberg (DE)
Medical University of Graz (AT)
Corresponding author: Pilz, Stefan
Tomaschitz, Andreas
ORCID: Pilz, Stefan
Drechsler, Christiane
Meinitzer, Andreas
März, Winfried
Pieber, Thomas R.
Tomaschitz, Andreas
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2012-01-01
Volume: 97
Issue: 1
Pages: E75-E79
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2011-2183
OpenAlex: W2074546237
Cited by: 118
References: 21
Citations by year: 2026: 6 · 2025: 5 · 2024: 4 · 2023: 5 · 2022: 8 · 2021: 8 · 2020: 14 · 2019: 10 · 2018: 7 · 2017: 7 · 2016: 6 · 2015: 10 · 2014: 9 · 2013: 8 · 2012: 11
FWCI: 7.34
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
Pure Amsterdam UMC (submittedVersion, other-oa)
Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders: Austrian Federal Ministry of Economy, Family and Youth
Oesterreichische Nationalbank (13905, 825329)
Bundesministerium für Verkehr, Innovation und Technologie
Steirische Wirtschaftsförderungsgesellschaft
Karl-Franzens-Universität Graz
Medizinische Universität Graz
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
Keywords: primary aldosteronism, secondary hyperparathyroidism, parathyroid hormone, essential hypertension, mineralocorticoid receptor antagonists, adrenal surgery, hypercalciuria, vitamin D metabolism, serum calcium, endocrine hypertension
MeSH terms: Adult, Aged, Aldosterone, Blood Pressure, Clinical Trials as Topic, Cross-Sectional Studies, Data Interpretation, Statistical, Female, Follow-Up Studies, Humans, Hyperaldosteronism, Hyperparathyroidism, Hypertension, Male, Middle Aged, Parathyroid Hormone, Renin-Angiotensin System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hyperparathyroidism in Patients with Primary Aldosteronism: Cross-Sectional and Interventional Data from the GECOH Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks